ATE507286T1 - Immunisierung von fischen gegen virusinfektion - Google Patents

Immunisierung von fischen gegen virusinfektion

Info

Publication number
ATE507286T1
ATE507286T1 AT03780585T AT03780585T ATE507286T1 AT E507286 T1 ATE507286 T1 AT E507286T1 AT 03780585 T AT03780585 T AT 03780585T AT 03780585 T AT03780585 T AT 03780585T AT E507286 T1 ATE507286 T1 AT E507286T1
Authority
AT
Austria
Prior art keywords
immunization
virus infection
against virus
fish against
fish
Prior art date
Application number
AT03780585T
Other languages
English (en)
Inventor
Moshe Kotler
Ayana Benet
Izhak Bejerano
Nissim Chen
Marina Hutoran
Ariel Ronen
Original Assignee
Yissum Res Dev Co
Ministry Of Agricultural And Rural Dev Dept Of Fisheries And Aquaculture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co, Ministry Of Agricultural And Rural Dev Dept Of Fisheries And Aquaculture filed Critical Yissum Res Dev Co
Application granted granted Critical
Publication of ATE507286T1 publication Critical patent/ATE507286T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00061—Methods of inactivation or attenuation
    • C12N2710/00064—Methods of inactivation or attenuation by serial passage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/03—Herpetoviridae, e.g. pseudorabies virus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
AT03780585T 2003-01-01 2003-12-22 Immunisierung von fischen gegen virusinfektion ATE507286T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL15377503A IL153775A0 (en) 2003-01-01 2003-01-01 Immunizing fish against viral infection
PCT/IL2003/001097 WO2004061093A1 (en) 2003-01-01 2003-12-22 Immunizing fish against viral infection

Publications (1)

Publication Number Publication Date
ATE507286T1 true ATE507286T1 (de) 2011-05-15

Family

ID=29798413

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03780585T ATE507286T1 (de) 2003-01-01 2003-12-22 Immunisierung von fischen gegen virusinfektion

Country Status (12)

Country Link
US (1) US7351527B2 (de)
EP (1) EP1578959B1 (de)
JP (2) JP4690049B2 (de)
CN (1) CN100535108C (de)
AT (1) ATE507286T1 (de)
AU (1) AU2003288510A1 (de)
DE (1) DE60336927D1 (de)
DK (1) DK1578959T3 (de)
IL (2) IL153775A0 (de)
PL (1) PL209978B1 (de)
RU (1) RU2369635C2 (de)
WO (1) WO2004061093A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5109114B2 (ja) * 2006-02-24 2012-12-26 国立大学法人三重大学 魚類抗体産生の新規検出法
JP5239023B2 (ja) * 2006-04-13 2013-07-17 国立大学法人東京海洋大学 コイヘルペスウイルス（ｋｈｖ）病用ｄｎａワクチン
JP5567244B2 (ja) * 2006-06-06 2014-08-06 共立製薬株式会社 魚類ストレプトコッカス・ディスガラクティエを抗原とする不活化ワクチン
ATE547118T1 (de) * 2007-08-28 2012-03-15 Univ Liege Rekombinanter koi-herpesvirus (khv) oder cyprinid-herpesvirus 3 (cyhv-3) und impfstoff zur prävention einer von khv/cyhv-3 bei cyprinus carpio carpio oder cyprinus carpio koi verursachten erkrankung
EP2031065A1 (de) * 2007-08-28 2009-03-04 Université de Liège Rekombinanter Koi-Herpesvirus (KHV) oder Cyprinid-Herpesvirus 3 (CyHV-3) und Impfstoff zur Prävention einer von KHV/CyHV-3 bei Cyprinus carpio carpio oder Cyprinus carpio (Koi) verursachten Erkrankung
JP2010143860A (ja) * 2008-12-19 2010-07-01 Chisso Corp タンパク質の安定化剤
JP5462518B2 (ja) * 2009-04-09 2014-04-02 公益財団法人ヒューマンサイエンス振興財団 抗体精製方法
EP2487241A1 (de) 2011-02-09 2012-08-15 Westfälische Wilhelms-Universität Münster RNAi-Agenzien und -Zusammensetzungen, die als Therapeutika für Karpfen von Nutzen sind
UA114719C2 (uk) * 2011-12-30 2017-07-25 Гесваль С.А. Рекомбінантний герпесвірус кої (khv) і вакцина для профілактики захворювання, що викликається khv
RU2663244C2 (ru) * 2013-03-15 2018-08-03 Атлантиум Текнолоджиз Лтд. Система и способ для инактивации вируса инфекционного панкреатического некроза (ipnv) посредством оптимизированного ультрафиолетового излучения
WO2014185439A1 (ja) * 2013-05-15 2014-11-20 独立行政法人水産総合研究センター コイ科ヘルペスウイルス－２（Ｃｙｐｒｉｎｉｄ ｈｅｒｐｅｓｖｉｒｕｓ－２：ＣｙＨＶ－２）感染症用ワクチンおよびその製造方法、ならびにＣｙＨＶ－２ウイルス製造方法
CN103430936A (zh) * 2013-09-06 2013-12-11 中国水产科学研究院黑龙江水产研究所 一种用于鱼类基因组dna提取的鱼鳍组织的制备方法
IL230970A0 (en) * 2014-02-13 2014-09-30 Univ Ramot Tilapia virus vaccines
CN104774802B (zh) * 2015-04-27 2017-12-08 上海海洋大学 银鲫鱼背鳍细胞系
RU2640346C1 (ru) * 2016-08-11 2017-12-27 Федеральное государственное бюджетное образовательное учреждение высшего образования "Государственный аграрный университет Северного Зауралья" (ФГБОУ ВО ГАУ Северного Зауралья) Способ антиоксидантной защиты мальков карпа
WO2020127941A2 (en) 2018-12-21 2020-06-25 Intervet International B.V. Serum free intracellular pathogen vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780448A (en) * 1995-11-07 1998-07-14 Ottawa Civic Hospital Loeb Research DNA-based vaccination of fish

Also Published As

Publication number Publication date
DK1578959T3 (da) 2011-08-15
JP2011024584A (ja) 2011-02-10
JP4690049B2 (ja) 2011-06-01
RU2005120158A (ru) 2006-01-20
RU2369635C2 (ru) 2009-10-10
CN100535108C (zh) 2009-09-02
JP2006512078A (ja) 2006-04-13
IL153775A0 (en) 2003-07-31
US20060013828A1 (en) 2006-01-19
WO2004061093A1 (en) 2004-07-22
DE60336927D1 (de) 2011-06-09
PL376441A1 (en) 2005-12-27
PL209978B1 (pl) 2011-11-30
EP1578959A1 (de) 2005-09-28
EP1578959B1 (de) 2011-04-27
AU2003288510A8 (en) 2004-07-29
AU2003288510A1 (en) 2004-07-29
IL169412A (en) 2011-04-28
US7351527B2 (en) 2008-04-01
CN1742083A (zh) 2006-03-01

Similar Documents

Publication Publication Date Title
ATE507286T1 (de) Immunisierung von fischen gegen virusinfektion
ATE451119T1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
ATE426412T1 (de) Adjuvante influenza-vakzine
NO20054608L (no) Influensavirusvaksine
EA201991762A1 (ru) Вакцины против коронавируса свиней
DE60202877D1 (de) Gezieltes antikörper-verfahren
DK1487485T3 (da) Imidazoquinolinadjuvanser til DNA-vacciner
DK1409692T3 (da) Nye peptider afledt af G-proteinet fra RSV, og anvendelse heraf i en vaccine
DE60037900D1 (de) Chlamydia antigene und entsprechende dna-fragmente und ihre verwendungen
DE60226175D1 (de) Mycobakterieller impfstoff
DK1471936T3 (da) HIV-Vaccine og fremgangsmåde til anvendelse
ATE456958T1 (de) Mannose als adjuvant für intranasale vakzine
DE60222296D1 (de) Impfstoff von umhüllten viren und verfahren zu seiner herstellung
AR047581A1 (es) Vacunas de calicivirus felino
EE200200157A (et) Vaktsiin
WO2003103570A3 (en) Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles
MA37432A1 (fr) Virus modifié de la maladie de marek, et vaccins préparés à partir de celui-ci
ATE424844T1 (de) Kombinationsvakzine für geflügel
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
DE602004028512D1 (de) Rekombinante vakzine gegen infektion mit dem japanischen enzephalitis-virus äjevü und verfahren davon
BRPI0604365A (pt) polipeptìdeo isolado, composição de vacina anti-carrapato de múltiplas espécies, e, uso dos mesmos
HUP0402548A2 (hu) Madárembrió-részecskékből álló biomassza vírusantigének előállítására
CY1116907T1 (el) Ανασυνδυασμενα εμβολια κατα κωπηποδων καλιγιδων (θαλασσιων ψειρων) και αλληλουχιες αντιγονων αυτων
WO2002096940A3 (en) Attenuated very virulent infectious bursal disease virus
ATE388231T1 (de) Fischimpstoff gegen piscirickettsia salmonis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties